Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
World Journal of Gastroenterology|August 14, 2015
Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Satoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki, et al.
Journal of Gastroenterology|November 10, 2023
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducersYuki Kojima, Mamoru Tanaka, Makiko Sasaki, et al.
International Journal of Surgical Oncology|July 11, 2012
Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer TreatmentSatoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki, et al.
Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi|May 10, 2026
Colonic transit study in patients with chronic constipation using Japanese-made radiopaque markersTakeshi Kamiya, Eiji Kubota, Keiji Ozeki, et al.
Clinical and Experimental Gastroenterology|April 28, 2015
Managing refractory Crohn's disease: challenges and solutionsSatoshi Tanida, Keiji Ozeki, Tsutomu Mizoshita, et al.
The American Journal of Pathology|December 30, 2014
Gastric mesenchymal myofibroblasts maintain stem cell activity and proliferation of murine gastric epithelium in vitroTakahito Katano, Akifumi Ootani, Tsutomu Mizoshita, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 7, 2017
Bovine lactoferrin and Crohn's disease: a case studyDavid B Alexander, Masaaki Iigo, Mohamed Abdelgied, et al.
Journal of Clinical Medicine Research|October 23, 2015
Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative ColitisSatoshi Tanida, Tsutomu Mizoshita, Hirotada Nishie, et al.
Case Reports in Gastroenterology|January 24, 2013
Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's DiseaseKeiji Ozeki, Satoshi Tanida, Tsutomu Mizoshita, et al.
Journal of Clinical Medicine Research|December 2, 2014
The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitisSatoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki, et al.
Pageof 7